lasalocid
النصوص أدناه منقولة حرفياً وبلغتها الأصلية من نشرات الأدوية البيطرية المعتمدة لدى إدارة الغذاء والدواء الأمريكية (FDA) وقاعدة بيانات DailyMed.
دواعي الاستعمال (95)
Cattle (67)
Cattle (heifers)
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.
When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. For use only in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.
MGA® and Bovatec® and Tylan™
Cattle (heifers)
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes.
For heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
HeifermaX® 500 plus Bovatec® and Tylan™
Cattle (heifers)
For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers fed in confinement for slaughter.
When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. Melengestrol acetate is only for use in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive lasalocid concentrations could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.
MGA® and Bovatec® and Tylan™
Cattle (heifers)
For increased rate of weight gain improved feed efficiency, and suppression of estrus (heat).
For heifers being fed in confinement for slaughter
HeifermaX® 500 plus Bovatec®
Pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers)
For increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers).
Daily intakes of lasalocid in excess of 200 mg/head/day have not been shown to be more effective than 200 mg/head/day. Safety of lasalocid in unapproved species has not been established.Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers)
For increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in pasture cattle (slaughter, stocker, feeder cattle, beef replacement heifers).
Daily lasalocid intakes in excess of 200 mg/head/day have not been shown to be more effective than 200 mg/head/day. Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers)
For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in pasture cattle under 700 pounds (slaughter, stocker, feeder cattle, beef replacement heifers).
Daily lasalocid intakes in excess of 200 mg/head/day have not been shown to be more effective than 200 mg/head/day. Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (fed in confinement for slaughter)
For improved feed efficiency, increased rate of weight gain and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter.
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (fed in confinement for slaughter)
For improved feed efficiency, increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in cattle fed in confinement for slaughter.
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (fed in confinement for slaughter)
For improved feed efficiency, increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in cattle under 700 pounds fed in confinement for slaughter.
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (fed in confinement for slaughter)
For improved feed efficiency and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle fed in confinement for slaughter.
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Beef Cattle (weighing up to 800 pounds)
For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for the treatment of bacterial enteritis caused by E. coli and bacterial pneumonia caused by P. multocida organisms susceptible to chlortetracycline in cattle weighing up to 800 pounds.
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Beef Cattle (weighing up to 800 pounds)
For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in beef cattle weighing up to 800 pounds.
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (weighing less than 700 pounds)
For the control of coccidiosis caused by Eimeria bovis and Eimeria zuernii and for control of active infection of anaplasmosis caused by Anaplasmosis marginale susceptible to chlortetracycline in beef cattle under 700 pounds.
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Pasture Cattle (Slaughter, Stocker, Feeder Cattle, and Dairy and Beef Replacement Heifers).
For increased rate of weight gain in pasture cattle.
Feed continuously on a free choice basis at a rate of not less than 60 milligrams nor more than 200 milligrams of lasalocid per head per day.
Purina Sugar Mag Block 1440 BVT Medicated Mineral Block
Pasture Cattle (Slaughter, Stocker, and Feeder Cattle and Beef Replacement Heifers)
For increased rate of weight gain in pasture cattle (slaughter, stocker, and feeder cattle and beef replacement heifers).
Crystalyx® Iono-Lyx®
Beef Calves less than 2 months of age and dairy calves
For control of coccidiosis caused by Eimeria bovis and E. zuernii in beef calves less than 2 months of age and dairy calves.
Bovatec® 150 FP
Cattle (Up to 800 Lbs)
For control of coccidiosis caused by Eimeria bovis and E. zuernii in cattle up to 800 lbs.
Bovatec® 150 FP
Cattle (Up to 800 Lbs)
For control of coccidiosis caused by Eimeria bovis and E. zuernii.
Hand feed continuously to provide not more than 360 mg per day.
Bovatec® 68 Type A Medicated Article
Growing Beef Steers and Heifers on Pasture (Stocker, Feeder, and Slaughter) and Replacement Beef and Dairy Heifers
For increased rate of weight gain in growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef and dairy heifers. For increased rate of weight gain in growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef and dairy heifers Feed on a free-choice basis at a rate of 60 to 300 mg lasalocid sodium per head per day. Intakes of lasalocid sodium greater than 200 mg per head per day have not been shown to be more effective than 200 mg per head per day. Type C free-choice medicated feed must be manufactured under a medicated feed mill license utilizing an FDA approved formulation.
Bovatec® 91
Growing Beef Steers and Heifers on Pasture (Stocker, Feeder, and Slaughter) and Replacement Beef and Dairy Heifers
For increased rate of weight gain in growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef and dairy heifers.
Bovatec® 150 FP
Growing Beef Steers and Heifers Fed in Confinement for Slaughter
For increased rate of weight gain and improved feed efficiency growing beef steers and heifers fed in confinement for slaughter.
Bovatec® 150 FP
Growing Beef Steers and Heifers Fed in Confinement for Slaughter
For improved feed efficiency in growing beef steers and heifers fed in confinement for slaughter.
Bovatec® 150 FP
Feedlot Cattle
For improved feed efficiency and increased rate of weight gain in cattle being fed in confinement for slaughter
Feed continuously to provide not less than 250 mg nor more than 360 mg per head per day
Bovatec® 68 Type A Medicated Article
Feedlot Cattle
For improved feed efficiency in cattle being fed in confinement for slaughter,
Feed continuously to provide not less than 100 mg nor more than 360 mg per head per day.
Bovatec® 68 Type A Medicated Article
Pasture Cattle (Slaughter, Stocker, Feeder Cattle, and Beef and Dairy Heifers)
For increased rate of weight gain, feed continuously on a free-choice basis
A medicated feed mill license is required when free-choice feed is manufactured using a proprietary formula and/or specifications. Free-choice feed formulations must be FDA-approved. Daily lasalocid intakes in excess of 200 mg per head per day have not been shown to be more effective than 200 mg lasalocid per head per day. NOTE: Coccidiosis may occur when young pasture cattle are co-mingled with adult cattle passing coccidial oocysts.
Bovatec® 68 Type A Medicated Article
Pasture Cattle (Slaughter, Stocker, Feeder Cattle, and Beef and Dairy Heifers)
For increased rate of weight gain
The drug must be contained in at least 1 pound of feed and fed continuously on a daily basis.Daily lasalocid intakes in excess of 200 mg per head per day have not been shown to be more effective than 200 mg lasalocid per head per day. NOTE: Coccidiosis may occur when young pasture cattle are co-mingled with adult cattle passing coccidial oocysts.
Bovatec® 68 Type A Medicated Article
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes in heifers fed in confinement for slaughter.
When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. For use only in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.
MGA®/ Bovatec®/ Tylovet® 100
For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat) in heifers fed in confinement for slaughter.
When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. Melengestrol acetate is only for use in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive lasalocid concentrations could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.
MGA®/ Bovatec®/ Tylovet® 100
Cattle (growing beef steers and heifers fed in confinement for slaughter)
For increased rate of weight gain, improved feed efficiency and for the reduction of the incidence of liver abscesses in growing beef steers and heifers fed in confinement for slaughter.
Bovatec® and TM®
Cattle (Heifers)
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), and reduced incidence of liver abscesses.
For heifers being fed in confinement for slaughter.
Bovatec® / MGA® 100 / Tylan®
Cattle (Growing beef heifers fed in confinement for slaughter)
For increased rate of weight gain, improved feed efficiency, and suppression of estrus (heat).
MGA® and Bovatec®
Cattle (growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture)
For increased rate of weight gain.
MoorMan's® Cattle Minerals BT
Cattle fed in confinement for slaughter
For improved feed efficiency and increased rate of weight gain and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle fed in confinement for slaughter
For improved feed efficiency and increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle fed in confinement for slaughter
For improved feed efficiency and treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle fed in confinement for slaughter under 700 lbs
For improved feed efficiency and increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle fed in confinement for slaughter under 700 lbs
For improved feed efficiency and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Pasture Cattle (slaughter, stocker, feeder, dairy and beef replacement heifers)
For increased rate of weight gain and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Pasture Cattle (slaughter, stocker, feeder, and beef replacement heifers)
For increased rate of weight gain and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Pasture Cattle over 700 lb (slaughter, stocker, feeder, beef replacement heifers)
For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Pasture cattle under 700 lbs (slaughter, stocker, feeder, beef replacement heifers)
For increased rate of weight gain and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle weighing up to 800 lbs
For control of coccidiosis caused by Eimeria bovis and E. zuernii and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Beef Cattle weighing up to 800 lbs
For control of coccidiosis caused by Eimeria bovis and E. zuernii and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Beef cattle under 700 lbs
For control of coccidiosis caused by Eimeria bovis and E. zuernii and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Beef steers and heifers fed in confinement for slaughter
For use as an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever.
Aureo S 700® and Bovatec®
Beef steers and heifers fed in confinement for slaughter
For improved feed efficiency and increased rate of weight gain.
Aureo S 700® and Bovatec®
Beef steers and heifers fed in confinement for slaughter
For improved feed efficiency.
Aureo S 700® and Bovatec®
Beef cattle up to 800 lbs
For use as an aid in the maintenance of weight gains in the presence of respiratory disease such as shipping fever.
Aureo S 700® and Bovatec®
Beef cattle up to 800 lbs
For control of coccidiosis caused by Eimeria bovis and E. zuernii.
Aureo S 700® and Bovatec®
Growing beef heifers fed in confinement for slaughter up to 800 pounds
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for control of coccidiosis caused by Eimeria bovis and E. zuernii, and treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
MGA® and Bovatec® and Aureomycin®
Growing beef heifers fed in confinement for slaughter up to 800 pounds
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for control of coccidiosis caused by Eimeria bovis and E. zuernii, and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.
MGA® and Bovatec® and Aureomycin®
Growing beef heifers fed in confinement for slaughter under 700 pounds
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), control of coccidiosis caused by Eimeria bovis and E. zuernii, and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
MGA® and Bovatec® and Aureomycin®
Replacement beef heifers on pasture over 700 pounds
For suppression of estrus (heat), increased rate of weight gain, and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
MGA® and Bovatec® and Aureomycin®
Replacement dairy heifers on pasture less than 20 months of age and replacement beef heifers on pasture
For suppression of estrus (heat), increased rate of weight gain, and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
MGA® and Bovatec® and Aureomycin®
Replacement beef heifers on pasture
For suppression of estrus (heat), increased rate of weight gain, and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.
MGA® and Bovatec® and Aureomycin®
Replacement beef heifers on pasture under 700 pounds
For suppression of estrus (heat), increased rate of weight gain, and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
MGA® and Bovatec® and Aureomycin®
Replacement beef heifers up to 800 pounds
For suppression of estrus (heat), control of coccidiosis caused by Eimeria bovis and E. zuernii, and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline.
MGA® and Bovatec® and Aureomycin®
Replacement dairy heifers up to 800 pounds and less than 20 months of age and replacement beef heifers up to 800 pounds
For suppression of estrus (heat), control of coccidiosis caused by Eimeria bovis and E. zuernii, and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline
MGA® and Bovatec® and Aureomycin®
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for control of coccidiosis caused by Eimeria bovis and E. zuernii, and treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline in growing beef heifers fed in confinement for slaughter up to 800 pounds.
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
For suppression of estrus (heat), control of coccidiosis caused by Eimeria bovis and E. zuernii, and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline in replacement dairy heifers up to 800 pounds and less than 20 months of age and replacement beef heifers up to 800 pounds.
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), for control of coccidiosis caused by Eimeria bovis and E. zuernii, and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in growing beef heifers fed in confinement for slaughter up to 800 pounds.
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
For increased rate of weight gain, improved feed efficiency, suppression of estrus (heat), control of coccidiosis caused by Eimeria bovis and E. zuernii, and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in growing beef heifers fed in confinement for slaughter under 700 pounds.
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
For suppression of estrus (heat), increased rate of weight gain, and for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline in replacement dairy heifers on pasture less than 20 months of age and replacement beef heifers on pasture.
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
For suppression of estrus (heat), control of coccidiosis caused by Eimeria bovis and E. zuernii, and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in replacement beef heifers up to 800 pounds.
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
For suppression of estrus (heat), increased rate of weight gain, and for control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline in replacement beef heifers on pasture.
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
For suppression of estrus (heat), increased rate of weight gain, and for control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline in replacement beef heifers on pasture under 700 pounds.
MGA® and Bovatec® and Deracin™
Chickens (11)
Chickens (broilers)
For prevention of coccidiosis caused by E. tenella, E. necatrix, E. acervulina, E. brunetti E. mivati and E. maxima; as an aid in the reduction of lesions due to E. tenella; and for increased rate of weight gain (10 grams per ton) or improved feed efficiency (30 grams per ton).
For broiler chickens only. Feed continuously as sole ration. Withdraw 5 days before slaughter.
Avatec® / 3-Nitro® / Albac®
Chickens (broilers)
For prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima; as an aid in the reduction of lesions due to E. tenella; and for increased rate of weight gain
For broiler chickens only. Feed continuously as sole ration. Withdraw 5 days before slaughter.
3-Nitro® / Avatec® / Flavomycin®
Broiler Chickens
For the prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for increased rate of weight gain and improved feed efficiency in broiler chickens.
Feed continuously as the sole ration. For broiler chickens only.
Avatec® / Baciferm®
Broiler Chickens
For the prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima in broiler chickens.
Avatec®
Chickens (broilers and fryers)
For prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima; as an aid in the reduction of lesions due to E. tenella; and for increased rate of weight gain
For broiler or fryer chickens only. Feed continuously as the sole ration. Withdraw 5 days before slaughter.
3-Nitro® / Avatec® / Fortracin Broiler Premix
Chickens (broilers and fryers)
For prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for increased rate of weight gain and improved feed efficiency
For broiler and fryer chickens only. Feed continuously as sole ration. Do not feed to laying chickens.
Avatec® / Stafac®
Chickens (broilers or fryers)
For the prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima and as an aid in the reduction of lesions due to E. tenella
For broiler or fryer chickens only. Feed continuously as the sole ration. As sole source of organic arsenic. Withdraw 5 days before slaughter.
3-Nitro® / Avatec® / Lincomycin
Chickens (broiler or fryer)
For the prevention of coccidiosis caused by Eimeria mivati, E. brunetti, E. tenella, E. acervulina, E. maxima, and E. necatrix; for increased rate of weight gain and improved feed efficiency.
For broiler and fryer chickens only. Feed continuously as sole ration. Withdraw 5 days before slaughter. Type C feed must be used within 4 weeks of manufacture. As lincomycin hydrochloride monohydrate.
Avatec® / Lincomix®
Chicken (broilers)
For the prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima; reduction of lesions due to E. tenella; prevention of necrotic enteritis caused by or complicated by Clostridium spp. or other susceptible organisms.
Feed continuously as the sole ration. As sole source of organic arsenic. Withdraw 5 days before slaughter.
3-Nitro® / Avatec® / BMD®
Broiler and fryer Chickens
For the prevention of necrotic enteritis caused by Clostridium perfringens susceptible to virginiamycin and for the prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati and E. maxima.
Do not feed to laying chickens. For broiler or fryer chickens only. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Stafac® and Avatec®
Broiler chickens
For the prevention of coccidiosis caused by Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima, and for the control of necrotic enteritis caused or complicated by Clostridium spp. or other organisms susceptible to lincomycin in broiler chickens. Not for use in laying hens, breeder chickens, or turkeys.
Avatec® and LINCOMIX®
Turkeys (5)
For the prevention of coccidiosis caused by Eimeria meleagrimitis, E. gallopavonis, and E. adenoeides, and for increased rate of weight gain and improved feed efficiency in growing turkeys.
Feed continuously as the sole ration For growing turkeys only.
Avatec® / Stafac®
Growing Turkeys
For the prevention of coccidiosis caused by Eimeria meleagrimitis, E. gallopavonis, and E. adenoeides, and for increased rate of weight gain and improved feed efficiency in growing turkeys.
Feed continuously as the sole ration. For growing turkeys only.
Avatec® / BMD®
Growing Turkeys
For the prevention of coccidiosis caused by Eimeria meleagrimitis, E. gallopavonis, and E. adenoeides in growing turkeys.
Avatec®
Turkeys (Growing)
For increased rate of weight gain, improved feed efficiency, and improved pigmentation in growing turkeys.
For growing turkeys only. Use as sole source of organic arsenic.
Avatec® plus 3-Nitro®
Turkeys (Growing)
For the prevention of coccidiosis caused by Eimeria meleagrimitis, E. gallopavonis, and E. adenoeides.
For growing turkeys only. Use as sole source of organic arsenic.
Avatec® plus 3-Nitro®
Rabbits (2)
Rabbits up to 6 ½ weeks of age
For the prevention of coccidiosis caused by Eimeria stiedae in rabbits up to 6 ½ weeks of age.
Avatec®
For prevention of coccidiosis caused by Eimeria stiedae.
Feed as the sole ration for up to 6½ weeks of age.
Bovatec® 68 Type A Medicated Article
Sheep (2)
Sheep Maintained in Confinement
For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata in sheep maintained in confinement.
Bovatec® 150 FP
For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata in sheep maintained in confinement.
Feed continuously to provide not less than 15 mg nor more than 70 mg per head per day depending on body weight.
Bovatec® 68 Type A Medicated Article
Game birds (1)
Chukar Partridges up to 8 weeks of age
For the prevention of coccidiosis caused by Eimeria legionensis in chukar partridges up to 8 weeks of age.
Avatec®
Please see NADA 140-288 for more information. (1)
Please see NADA 140-288 for more information.
Please see NADA 140-288 for more information.
Bovatec® / MGA® 100
دون تحديد نوع الحيوان (6)
Use directions Species Dose Indications for use Cattle Fed in Confinement for Slaughter: Dose: 10-30 grams lasalocid per ton of total ration (90% dray matter) Indications for Use: For improved feed efficiency in cattle fed in confinement for slaughter, feed continuously to provide not less than 100 mg no more than 360 mg per head per day. Dose: 25-30 grams lasalocid per ton of total ration (90% dry matter) Indications: For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter, feed continuously to provide not less than 250 mg not more than 360 mg per head per day. Pasture Cattle – slaughter, stocker, feeder cattle, and dairy and beef replacement heifers: Dose: 60-300 mg lasalocid per head/day Indications: For increased rate of weight gain. The drug must be contained in at least 1 pound of feed and fed continuously on a daily basis. Dose: 60-300 mg lasalocid per head/day Indications: For increased rate of weight gain, feed continuously on a free-choice basis. A medicated feed mill license is required when free choice feed is manufactured using a proprietary formula and/or specifications. Free-choice feed formulations must be FDA-approved. Daily lasalocid intakes in excess of 200 mg per head per day have not been shown to be more effective than 200 mg lasalocid per head per day. NOTE: Coccidiosis may occur when young pasture cattle are co-mingled with adult cattle passing coccidial oocysts. Cattle: Dose: 1 mg lasalocid per 2.2 lbs body weight/day Indications: For control of coccidiosis caused by Eimeria bovis and E. zuernii in cattle up to 800 lbs. Hand feed continuously to provide not more than 360 mg per day. Sheep: Dose: 20-30 grams lasalocid per ton of total ration (90% dry matter) Indications: For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata in sheep maintained in confinement. Feed continuously to provide not less than 15 mg nor more than 70 mg per head per day depending on body weight.
Bovatec 15% (Lasalocid Sodium)
Species Dose Indications for use Growing beef steers and heifers fed in confinement for slaughter 10-30 grams lasalocid sodium per ton of total ration (90% dry matter) For improved feed efficiency: Feed as the sole ration to provide 100 to 360 mg lasalocid sodium per head per day. 25-30 grams lasalocid sodium per ton of total ration (90% dry matter) For increased rate of weight gain and improved feed efficiency: Feed as the sole ration to provide 250 to 360 mg lasalocid sodium per head per day. Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef and dairy heifers 60-300 mg lasalocid sodium per head/day For increased rate of weight gain. The drug must be contained in at least 1 pound of feed and fed continuously on a daily basis. 60-300 mg lasalocid sodium per head/day For increased rate of weight gain: Feed on a free-choice basis. Intakes of lasalocid sodium greater than 200 mg per head per day have not been shown to be more effective than 200 mg per head per day. Type C free-choice medicated feed must be manufactured under a medicated feed mill license utilizing an FDA approved formulation. NOTE: Coccidiosis may occur when young pasture cattle are co-mingled with adult cattle passing coccidial oocysts. Cattle up to 800 lbs 1 mg lasalocid sodium per 2.2 lbs body weight/day For control of coccidiosis caused by Eimeria bovis and E. zuernii. Hand feed to provide up to 360 mg lasalocid sodium per head per day. Sheep maintained in confinement 20-30 grams lasalocid sodium per ton of total ration (90% dry matter) For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata: Feed as the sole ration to provide 15 to 70 mg lasalocid sodium per head per day depending on the body weight.
Bovatec® 91
CATTLE: For improved feed efficiency and increased rate of weight gain when used in medicated feeds for cattle fed in confinement for slaughter. For increased rate of weight gain when used in medicated feeds for pasture cattle (slaughter, stocker, feeder cattle, and dairy and beef replacement heifers). For control of coccidiosis caused by Eimeria bovis and E. zuernii in cattle up to 800 lbs. SHEEP: For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva and E. intricata in sheep maintained in confinement.
Bovatec® Liquid 20
For the prevention of coccidiosis in Target Species: Caused by: Broiler Chickens: Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima Growing Turkeys: E. meleagrimitis, E. gallopavonis, E. adenoeides Rabbits up to 6 1/2 weeks of age: Eimeria stiedae Chukar Partridges up to 8 weeks of age: Eimeria legionensis
Avatec®
For use in the manufacture of medicated feeds only. For the prevention of coccidiosis in - Broiler and fryer chickens: Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima Growing Turkeys: E. meleagrimitis, E. gallopavonis, E. adenoeides Rabbits: E. stiedae Chukar Partridges: E. legionensis
Avatec 15% (Lasalocid Sodium)
For the prevention of coccidiosis in Target Species: Caused by: Broiler or Fryer Chickens: Eimeria tenella, E. necatrix, E. acervulina, E. brunetti, E. mivati, and E. maxima Growing Turkeys: E. meleagrimitis, E. gallopavonis, E. adenoeides Rabbits: Eimeria stiedae Chukar Partridges: Eimeria legionensis
Avatec®
التحذيرات (6)
دون تحديد نوع الحيوان (6)
HARMFUL IF SWALLOWED. CAUSES EYE IRRITATION. MATERIAL IS COMBUSTIBLE. DUST EXPLOSION HAZARD. CAUTION: For Manufacturing, Processing or Repacking FIRST AID: For EYE contact, immediatedly flush eyes with plenty of water for at least 15 minutes. Get medicat attention. If SWALLOWED, get medical attention immediately. Do not induce vomiting unless directed by medical personnel. Never give anything by mouth to an unconscious person. PRECAUTIONS: Do not generate dust or excuse to ignition sources. Ground and bond all transfer equipment. Use with adequate ventilation. Avoid contact with eyes. When handling use proper personal protective equipment. Wash thoroughly after handling. Store in a dry, well ventilated area. Store at or below 40°C. Keep container tightly closed when not in use. SEE MATERIAL SAFETY DATA SHEET FOR FURTHER HEALTH AND SAFETY INFORMATION
Lasalocid Sodium
IMPORTANT: Handling Information - Must be thoroughly mixed in feeds before use. When mixing and handling Lasalocid Type A Liquid Medicated Article use protective clothing and impervious gloves. Avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling.
Bovatec® Liquid 20
Handling Information - Must be thoroughly mixed in feeds before use. When mixing and handling lasalocid Type A medicated articles, use protective clothing, impervious gloves and a dust mask. Avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling.
Bovatec® 91
Not for use in humans. Keep out of reach of children. When mixing and handling lasalocid sodium Type A medicated articles, use protective clothing, impervious gloves and a dust mask. Avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling.
Bovatec® 91
When mixing and handling lasalocid Type A medicated article, use protective clothing, impervious gloves and a dust mask. Avoid contact with eyes. Operators should wash thoroughly with soap and water after handling.
Avatec®
No withdrawal period is required when used according to labeling. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
Bovatec® 150 FP
الجرعات (94)
Cattle (58)
Cattle (heifers)
Melengestrol acetate, 0.25 to 0.50 milligram per head per day in combination with lasalocid (as lasalocid sodium), 100 to 360 milligrams per head per day. To attain this amount: Add at the rate of 0.5 to 2.0 pounds per head a medicated feed (liquid) containing 0.125 to 1.0 milligram of melengestrol acetate per pound to a feed containing 10 to 30 grams of lasalocid per ton; or, Add at the rate of 0.5 to 2.0 pounds per head per day a medicated feed (liquid or dry) containing 0.125 to 1.0 milligram of melengestrol acetate plus 50 to 720 milligrams of lasalocid per pound to a ration of non-medicated feed to provide 0.25 to 0.5 milligram of melengestrol acetate and 100 to 360 milligrams of lasalocid per head per day.
Oral
For heifers being fed in confinement for slaughter
HeifermaX® 500 plus Bovatec®
Cattle (heifers)
Melengestrol acetate, 0.25 to 0.50 milligram per head per day, plus lasalocid (as lasalocid sodium), 100 to 360 milligrams per head per day, and tylosin (as tylosin phosphate), 90 milligrams per head per day. To attain this amount:Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate per pound to a medicated feed containing 10 to 30 grams of lasalocid and 8 to 10 grams of tylosin per ton; or Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate per pound plus 50 to 720 milligrams of lasalocid per pound to 8 to 10 grams of tylosin per ton.
Oral
For heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
HeifermaX® 500 plus Bovatec® and Tylan™
Cattle (heifers)
Feed 0.25 to 2.0 g/ton melengestrol acetate to heifers at the rate of 0.5 to 2.0 lb/hd/day as a top dress or mixed into a complete feed to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 100 to 1440 g/ton lasalocid to provide 100 to 360 mg lasalocid per head per day. Melengestrol acetate and lasalocid may be fed continuously throughout the time the heifers are being grown and finished for slaughter. May be fed to heifers in combination with a complete feed containing 8 to 10 g of tylosin per ton for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes.
Oral
When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. Melengestrol acetate is only for use in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive lasalocid concentrations could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.
MGA® and Bovatec® and Tylan™
Cattle (heifers)
Feed 0.25 to 2.0 g/ton melengestrol acetate to heifers at the rate of 0.5 to 2.0 lb/hd/day as a top dress or mixed into a complete feed to provide 0.25 to 0.5 mg melengestrol acetate per head lasalocid per day and 100 to 1440 g/ton lasalocid to provide 100 to 360 mg lasalocid per head per day and 90 to 360 g/ton tylosin to provide 90 mg tylosin per head per day. Melengestrol acetate, lasalocid, and tylosin may be fed continuously throughout the time the heifers are being grown and finished for slaughter.
Oral
When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. For use only in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.
MGA® and Bovatec® and Tylan™
Pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers)
Feed continuously on a hand-fed basis for not more than 5 days chlortetracycline (500 to 4000 g/ton) in combination with lasalocid (30 to 600 g/ton) to provide 10 mg chlortetracycline per lb body weight and 60 to 300 mg lasalocid per head per day in at least 1 pound of feed.
Oral
Daily intakes of lasalocid in excess of 200 mg/head/day have not been shown to be more effective than 200 mg/head/day. Safety of lasalocid in unapproved species has not been established.Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers)
Feed continuously on a hand-fed basis chlortetracycline (25 to 1100 g/ton) in combination with lasalocid (30 to 600 g/ton) to provide 0.5 mg chlortetracycline per lb body weight per day and 60 to 300 mg lasalocid per head daily in at least 1 pound of feed.
Oral
Daily lasalocid intakes in excess of 200 mg/head/day have not been shown to be more effective than 200 mg/head/day. Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Pasture cattle (slaughter, stocker, feeder cattle, dairy and beef replacement heifers)
Feed continuously on a hand-fed basis chlortetracycline (25 to 700 g/ton) in combination with lasalocid (30 to 600 g/ton) at a rate of 350 mg chlortetracycline and 60 to 300 mg lasalocid per head daily in at least 1 pound of feed.
Oral
Daily lasalocid intakes in excess of 200 mg/head/day have not been shown to be more effective than 200 mg/head/day. Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (fed in confinement for slaughter)
Feed continuously in complete feed for not more than 5 days chlortetracycline (500 to 1200 g/ton) in combination with lasalocid (25 to 30 g/ton) to provide 10 mg chlortetracycline per lb of body weight per day and 250 to 360 mg lasalocid per head per day.
Oral
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (fed in confinement for slaughter)
Feed continuously in complete feed for not more than 5 days chlortetracycline (50 to 2000 g/ton) in combination with lasalocid (10 to 30 g/ton) to provide 10 mg chlortetracycline per lb of body weight per day and 100 to 360 mg lasalocid per head per day.
Oral
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (fed in confinement for slaughter)
Feed continuously in complete feed chlortetracycline (25 to 42.2 g/ton) in combination with lasalocid (25 to 30 g/ton) at a rate of 350 mg chlortetracycline and 250 to 360 mg lasalocid per head daily.
Oral
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Beef Cattle (weighing up to 800 pounds)
Hand feed continuously chlortetracycline (500 to 4000 g/ton) in combination with lasalocid (30 to 181.8 g/ton) for not more than 5 days to provide 10 mg chlortetracycline per lb. body weight per day and 1 mg lasalocid per 2.2 lb. body weight per day to cattle weighing up to 800 lb. with a maximum of 360 mg of lasalocid per head per day.
Oral
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Beef Cattle (weighing up to 800 pounds)
Hand feed continuously chlortetracycline (25 to 2800 g/ton) in combination with lasalocid (30 to 181.8 g/ton) at a rate of 350 mg chlortetracycline per head and 1 mg lasalocid per 2.2 lb of body weight daily with a maximum of 360 mg of lasalocid per head per day.
Oral
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Cattle (weighing less than 700 pounds)
Hand feed continuously chlortetracycline (25 to 2800 g/ton) in combination with lasalocid (30 to 181 g/ton) at a rate of 350 mg chlortetracycline per head and 1 mg lasalocid per 2.2 lb of body weight daily with a maximum of 360 mg of lasalocid per head per day.
Oral
Safety of lasalocid in unapproved species has not been established. Do not allow horses or other equines access to feeds containing lasalocid.
Aureomycin® and Bovatec®
Pasture Cattle (Slaughter, Stocker, Feeder Cattle, and Dairy and Beef Replacement Heifers).
60-200 mg lasalocid/head/day
Oral
Feed continuously on a free choice basis at a rate of not less than 60 milligrams nor more than 200 milligrams of lasalocid per head per day.
Purina Sugar Mag Block 1440 BVT Medicated Mineral Block
Pasture Cattle (Slaughter, Stocker, and Feeder Cattle and Beef Replacement Heifers)
Feed continuously on a free-choice basis between 0.4 and 1.3 pounds per head daily to provide 60 to 200 milligrams lasalocid per head per daily. Feed at the rate of one container for every 10-30 head.
Oral
Crystalyx® Iono-Lyx®
Beef Calves less than 2 months of age and dairy calves
Thoroughly mix milk replacer powder with warm water and hand feed immediately at a rate of 1 mg lasalocid sodium per 2.2 lb body weight per day.
Oral
Bovatec® 150 FP
Cattle (Up to 800 Lbs)
Hand feed to provide 1 mg lasalocid sodium per 2.2 lbs body weight per day, up to 360 mg lasalocid sodium per head per day.
Oral
Bovatec® 150 FP
Cattle (Up to 800 Lbs)
1 mg lasalocid per 2.2 lbs body weight/day
Oral
Hand feed continuously to provide not more than 360 mg per day.
Bovatec® 68 Type A Medicated Article
Growing Beef Steers and Heifers on Pasture (Stocker, Feeder, and Slaughter) and Replacement Beef and Dairy Heifers
Feed on a free-choice basis at a rate of 60 to 300 mg lasalocid sodium per head per day. Intakes of lasalocid sodium greater than 200 mg per head per day have not been shown to be more effective than 200 mg per head per day. Type C free-choice medicated feed must be manufactured under a medicated feed mill license utilizing an FDA approved formulation.
Oral
Bovatec® 150 FP
Growing Beef Steers and Heifers on Pasture (Stocker, Feeder, and Slaughter) and Replacement Beef and Dairy Heifers
Feed at least 1 pound of Type C medicated feed to provide 60 to 300 mg lasalocid sodium per head per day. Intakes of lasalocid sodium greater than 200 mg per head per day have not been shown to be more effective than 200 mg per head per day.
Oral
Bovatec® 150 FP
Growing Beef Steers and Heifers Fed in Confinement for Slaughter
10 - 30 g lasalocid sodium per ton of Type C medicated feed. Feed as the sole ration to provide 100 to 360 mg lasalocid sodium per head per day.
Oral
Bovatec® 150 FP
Feedlot Cattle
25-30 grams lasalocid per ton of total ration (90% dry matter)
Oral
Feed continuously to provide not less than 250 mg nor more than 360 mg per head per day
Bovatec® 68 Type A Medicated Article
Pasture Cattle (Slaughter, Stocker, Feeder Cattle, and Beef and Dairy Heifers)
60-300 mg lasalocid per head/day
Oral
A medicated feed mill license is required when free-choice feed is manufactured using a proprietary formula and/or specifications. Free-choice feed formulations must be FDA-approved. Daily lasalocid intakes in excess of 200 mg per head per day have not been shown to be more effective than 200 mg lasalocid per head per day. NOTE: Coccidiosis may occur when young pasture cattle are co-mingled with adult cattle passing coccidial oocysts.
Bovatec® 68 Type A Medicated Article
Feed 0.25 to 2.0 g/ton melengestrol acetate to heifers at the rate of 0.5 to 2.0 lb/hd/day as a top dress or mixed into a complete feed to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 100 to 1440 g/ton lasalocid to provide 100 to 360 mg lasalocid per head per day. Melengestrol acetate and lasalocid may be fed continuously throughout the time the heifers are being grown and finished for slaughter. May be fed to heifers in combination with a complete feed containing 8 to 10 g of tylosin per ton for reduction of incidence of liver abscesses associated with Fusobacterium necrophorum and Arcanobacterium pyogenes.
Oral
When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. Melengestrol acetate is only for use in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive lasalocid concentrations could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.
MGA®/ Bovatec®/ Tylovet® 100
Feed 0.25 to 2.0 g/ton melengestrol acetate to heifers at the rate of 0.5 to 2.0 lb/hd/day as a top dress or mixed into a complete feed to provide 0.25 to 0.5 mg melengestrol acetate per head lasalocid per day and 100 to 1440 g/ton lasalocid to provide 100 to 360 mg lasalocid per head per day and 90 to 360 g/ton tylosin to provide 90 mg tylosin per head per day. Melengestrol acetate, lasalocid, and tylosin may be fed continuously throughout the time the heifers are being grown and finished for slaughter.
Oral
When tylosin is fed in combination with melengestrol acetate and lasalocid, the level of tylosin is limited to 90 mg/hd/day. For use only in heifers being fed in confinement for slaughter. Not effective in steers and spayed heifers. This combination may only be marketed as a pelleted product. Do not allow horses or other equines access to premixes or supplements containing lasalocid, as ingestion may be fatal. The safety of lasalocid in unapproved species has not been established. Mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep. When mixing and handling lasalocid, use protective clothing, impervious gloves and a dust mask, avoid contact with eyes. Operators should wash hands thoroughly with soap and water after handling. Use melengestrol acetate only as directed.
MGA®/ Bovatec®/ Tylovet® 100
Cattle (growing beef steers and heifers fed in confinement for slaughter)
Feed a Type C medicated feed containing 10 to 30 grams lasalocid sodium per ton and 7.5 grams oxytetracycline (from oxytetracycline quaternary salt) equivalent to oxytetracycline hydrochloride per ton to provide 100 mg to 360 mg lasalocid sodium per head per day and 75 mg oxytetracycline per head per day. Do not allow horses or other equines access to Type C feeds containing lasalocid as ingestion may be fatal. Safety of lasalocid for use in unapproved species has not been established.
Oral
Bovatec® and TM®
Cattle (Heifers)
Melengestrol acetate, 0.25 to 0.50 milligram per head per day, plus lasalocid (as lasalocid sodium), 100 to 360 milligrams per head per day, and tylosin (as tylosin phosphate), 90 milligrams per head per day. To attain this amount: Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate per pound to a medicated feed containing 10 to 30 grams of lasalocid and 8 to 10 grams of tylosin per ton; or Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate per pound plus 50 to 720 milligrams of lasalocid per pound to 4.5 to 18 pounds of a dry medicated feed containing 10 to 40 grams of tylosin per ton; or Add 0.5 to 2.0 pounds per head per day of a dry pelleted medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate (from a dry Type A article), 50 to 720 milligrams of lasalocid, and 45 to 180 milligrams of tylosin per pound to a ration of non-medicated feed.
Oral
For heifers being fed in confinement for slaughter.
Bovatec® / MGA® 100 / Tylan®
Cattle (Growing beef heifers fed in confinement for slaughter)
0.25 to 2 g/ton of melengestrol acetate to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 100 to 1,440 g/ton of lasalocid sodium to provide 100 to 360 mg lasalocid sodium per head per day. The melengestrol acetate and lasalocid sodium Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed into a complete feed prior to feeding. Or 0.25 to 2 g/ton of melengestrol acetate to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 10 to 30 g/ton of lasalocid sodium to provide 100 to 360 mg lasalocid sodium per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing 10 to 30 g/ton lasalocid sodium.
Oral
MGA® and Bovatec®
Cattle (growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture)
1,440 g/ton of lasalocid (as lasalocid sodium). Recommended consumption of MoorMan’s Cattle Minerals BT is 0.084 to 0.277 lb per head per day to provide 60 to 200 mg of lasalocid per head per day. A 7-day supply of this product may be put out at one time. Feed this product near watering or loafing areas and provide one feeder for each 15 to 20 head of cattle. Additional MoorMan’s Cattle Minerals BT should be put out when the current supply is 75% consumed.
Oral
MoorMan's® Cattle Minerals BT
Cattle fed in confinement for slaughter
Lasalocid 25 to 30 g/ton and chlortetracycline 500 to 1200 g/ton. Feed continuously in complete feed for not more than 5 days to provide 10 mg chlortetracycline per lb of body weight per day and not less than 250 mg or more than 360 mg lasalocid per head per day.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle fed in confinement for slaughter
Lasalocid 10 to 30 g/ton and chlortetracycline 500 to 2000 g/ton. Feed continuously in complete feed for not more than 5 days to provide 10 mg chlortetracycline per lb of body weight per day and not less than 100 mg or more than 360 mg lasalocid per head per day.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle fed in confinement for slaughter
Lasalocid 25 to 30 g/ton and chlortetracycline 25 to 42.2 g/ton. Feed continuously in complete feed at a rate of 350 mg chlortetracycline and not less than 250 mg or more than 360 mg lasalocid per head daily.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle fed in confinement for slaughter under 700 lbs
Lasalocid 25 to 30 g/ton and chlortetracycline 25 to 42.2 g/ton. Feed continuously in complete feed at a rate of 350 mg chlortetracycline and not less than 250 mg or more than 360 mg lasalocid per head daily.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Pasture Cattle (slaughter, stocker, feeder, dairy and beef replacement heifers)
Lasalocid 30 to 600 g/ton and chlortetracycline 500 to 4000 g/ton. Feed continuously on a hand fed basis for not more than 5 days to provide 10 mg chlortetracycline per lb of body weight per day and not less than 60 mg or more than 300 mg lasalocid per head per day in at least 1 lb of feed.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Pasture Cattle (slaughter, stocker, feeder, and beef replacement heifers)
Lasalocid 30 to 600 g/ton and chlortetracycline 25 to 700 g/ton. Feed continuously on a hand fed basis at a rate of 350 mg chlortetracycline and not less than 60 mg or more than 300 mg lasalocid per head daily in at least 1 pound of feed.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Pasture Cattle over 700 lb (slaughter, stocker, feeder, beef replacement heifers)
Lasalocid 30 to 600 g/ton and chlortetracycline 25 to 1100 g/ton. Feed continuously on a hand fed basis 0.5 mg per lb of body weight per day and not less than 60 mg or more than 300 mg lasalocid per head daily in at least 1 lb of feed.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Pasture cattle under 700 lbs (slaughter, stocker, feeder, beef replacement heifers)
Lasalocid 30 to 600 g/ton and chlortetracycline 25 to 700 g/ton. Feed continuously on a hand fed basis at a rate of 350 mg chlortetracycline and not less than 60 mg or more than 300 mg lasalocid per head daily in at least 1 pound of feed.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Cattle weighing up to 800 lbs
Lasalocid 30 to 181.8 g/ton and chlortetracycline 500 to 4000 g/ton. Hand feed continuously for not more than 5 days to provide 10 mg chlortetracycline per lb of body weight per day and 1 mg lasalocid per 2.2 lb body weight daily with a maximum of 360 mg of lasalocid per head per day.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Beef Cattle weighing up to 800 lbs
Lasalocid 30 to 181.8 g/ton and chlortetracycline 25 to 2800 g/ton. Hand feed continuously at a rate of 350 mg chlortetracycline per head and 1 mg lasalocid per 2.2 lb body weight daily with a maximum of 360 mg of lasalocid per head per day.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Beef cattle under 700 lbs
Lasalocid 30 to 181.8 g/ton and chlortetracycline 25 to 2800 g/ton. Hand feed continuously at a rate of 350 mg chlortetracycline per head and 1 mg lasalocid per 2.2 lb body weight daily with a maximum of 360 mg lasalocid per head per day.
Oral, in feed
Federal law restricts medicated feed containing this veterinary feed directive drug to use by or on the order of a licensed veterinarian.
Deracin® plus Bovatec®
Beef steers and heifers fed in confinement for slaughter
35 to 42.2 g/ton to provide 350 mg per head per day each of chlortetracycline and sulfamethazine (as Aureo S 700®). Feed continuously for 28 days.
Oral
Aureo S 700® and Bovatec®
Beef steers and heifers fed in confinement for slaughter
10 to 30 g/ton to provide 100 to 300 mg per head per day of lasalocid (as Bovatec®). Feed continuously for 28 days.
Oral
Aureo S 700® and Bovatec®
Beef cattle up to 800 lbs
30 to 181.8 g/ton to provide 1 mg per 2.2 lb body weight per day up to a maximum of 360 mg per head per day of lasalocid (as Bovatec®). Hand feed continuously for 28 days.
Oral
Aureo S 700® and Bovatec®
Beef cattle up to 800 lbs
35 to 700 g/ton to provide 350 mg per head per day each of chlortetracycline and sulfamethazine (as Aureo S 700®). Hand feed continuously for 28 days.
Oral
Aureo S 700® and Bovatec®
Growing beef heifers fed in confinement for slaughter up to 800 pounds
0.25 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.25 to 0.5 mg melengestrol acetate per head per day; 30 to 181.8 g/ton of lasalocid (as Bovatec®) to provide 1 mg lasalocid per 2.2lb. body weight per day with a maximum of 360 mg of lasalocid per head per day; and 500 to 4,000 g/ton of chlortetracycline (as Aureomycin®) to provide 10 mg chlortetracycline per lb. of body weight per day. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 5 days. After completing feeding of this combination, continue feeding a Type C top-dress medicated feed containing melengestrol acetate alone.
Oral
MGA® and Bovatec® and Aureomycin®
Growing beef heifers fed in confinement for slaughter up to 800 pounds
0.25 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.25 to 0.5 mg melengestrol acetate per head per day; 30 to 181.8 g/ton of lasalocid (as Bovatec®) at a rate of 1 mg lasalocid per 2.2 lb. body weight daily with a maximum of 360 mg of lasalocid per head per day; and 25 to 2,800 g/ton of chlortetracycline (as Aureomycin®) at a rate of 350 mg chlortetracycline per head daily. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline.
Oral
MGA® and Bovatec® and Aureomycin®
Growing beef heifers fed in confinement for slaughter under 700 pounds
0.25 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.25 to 0.5 mg melengestrol acetate per head per day; 30 to 181.8 g/ton of lasalocid (as Bovatec®) at a rate of 1 mg lasalocid per 2.2 lb. body weight daily with a maximum of 360 mg of lasalocid per head per day; and 25 to 2,800 g/ton of chlortetracycline (as Aureomycin®) at a rate of 350 mg chlortetracycline per head per day. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline.
Oral
MGA® and Bovatec® and Aureomycin®
Replacement beef heifers on pasture over 700 pounds
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day; 30 to 600 g/ton of lasalocid (as Bovatec®) to provide not less than 60 mg or more than 300 mg lasalocid per head daily in at least 1 pound of feed; and 25 to 1,100 g/ton of chlortetracycline (as Aureomycin®) to provide 0.5 mg chlortetracycline per lb. of body weight per day in at least 1 pound of feed. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 24 days.
Oral
MGA® and Bovatec® and Aureomycin®
Replacement dairy heifers on pasture less than 20 months of age and replacement beef heifers on pasture
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day; 30 to 600 g/ton of lasalocid (as Bovatec®) to provide not less than 60 mg or more than 300 mg lasalocid per head per day in at least 1 pound of feed; and 500 to 4,000 g/ton of chlortetracycline (as Aureomycin®) to provide 10 mg chlortetracycline per lb. of body weight per day in at least 1 pound of feed. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 5 days. After completing feeding of this combination, continue feeding a Type C top-dress medicated feed containing melengestrol acetate alone for a total time not exceeding 24 days of feeding.
Oral
MGA® and Bovatec® and Aureomycin®
Replacement beef heifers on pasture
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day; 30 to 600 g/ton of lasalocid (as Bovatec®) at a rate of not less than 60 mg or more than 300 mg lasalocid per head daily in at least 1 pound of feed; and 25 to 700 g/ton of chlortetracycline (as Aureomycin®) at a rate of 350 mg chlortetracycline per head daily in at least 1 pound of feed. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 24 days.
Oral
MGA® and Bovatec® and Aureomycin®
Replacement beef heifers on pasture under 700 pounds
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day; 30 to 600 g/ton of lasalocid (as Bovatec®) at a rate of not less than 60 mg or more than 300 mg lasalocid per head daily in at least 1 pound of feed; and 25 to 700 g/ton of chlortetracycline (as Aureomycin®) at a rate of 350 mg chlortetracycline per head daily in at least 1 pound of feed. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 24 days.
Oral
MGA® and Bovatec® and Aureomycin®
Replacement beef heifers up to 800 pounds
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day; 30 to 181.8 g/ton of lasalocid (as Bovatec®) at a rate of 1 mg lasalocid per 2.2 lb. body weight daily with a maximum of 360 mg of lasalocid per head per day; and 25 to 2,800 g/ton of chlortetracycline (as Aureomycin®) at a rate of 350 mg chlortetracycline per head daily. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 24 days.
Oral
MGA® and Bovatec® and Aureomycin®
Replacement dairy heifers up to 800 pounds and less than 20 months of age and replacement beef heifers up to 800 pounds
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day; 30 to 181.8 g/ton of lasalocid (as Bovatec®) to provide 1 mg lasalocid per 2.2lb. body weight per day with a maximum of 360 mg of lasalocid per head per day; and 500 to 4,000 g/ton of chlortetracycline (as Aureomycin®) to provide 10 mg chlortetracycline per lb. of body weight per day. The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 5 days. After completing feeding of this combination, continue feeding a Type C top-dress medicated feed containing melengestrol acetate alone for a total time not exceeding 24 days of feeding.
Oral
MGA® and Bovatec® and Aureomycin®
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day, 30 to 600 g/ton of lasalocid (as Bovatec®) to provide not less than 60 mg or more than 300 mg lasalocid per head per day in at least 1 pound of feed, and 500 to 4,000 g/ton of chlortetracycline (as Deracin™) to provide 10 mg chlortetracycline per lb of body weight per day in at least 1 pound of feed The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 5 days. After completing feeding of this combination, continue feeding a Type C top-dress medicated feed containing melengestrol acetate alone for a total time not exceeding 24 days of feeding.
Oral
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day, 30 to 181.8 g/ton of lasalocid (as Bovatec®) to provide 1 mg lasalocid per 2.2 lb body weight per day with a maximum of 360 mg of lasalocid per head per day, and 500 to 4,000 g/ton of chlortetracycline (as Deracin™) to provide 10 mg chlortetracycline per lb body weight per day The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C top-dressed medicated feed containing lasalocid and chlortetracycline for not more than 5 days. After completing feeding of this combination, continue feeding a Type C top-dress medicated feed containing melengestrol acetate alone for a total time not exceeding 24 days of feeding.
Oral
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day, 30 to 600 g/ton of lasalocid (as Bovatec®) to provide not less than 60 mg or more than 300 mg lasalocid per head daily in at least 1 pound of feed, and 25 to 1,100 g/ton of chlortetracycline (as Deracin™) to provide 0.5 mg chlortetracycline per lb of body weight per day in at least 1 pound of feed The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C top-dressed medicated feed containing lasalocid and chlortetracycline for not more than 24 days.
Oral
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day, 30 to 600 g/ton of lasalocid (as Bovatec®) at a rate of not less than 60 mg or more than 300 mg lasalocid per head daily in at least 1 pound of feed, and 25 to 700 g/ton of chlortetracycline (as Deracin™) at a rate of 350 mg chlortetracycline per head daily in at least 1 pound of feed The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C top-dressed medicated feed containing lasalocid and chlortetracycline for not more than 24 days.
Oral
MGA® and Bovatec® and Deracin™
Growing beef heifers fed in confinement for slaughter and replacement beef and dairy heifers
0.5 to 2 g/ton of melengestrol acetate (as MGA®) to deliver 0.5 mg melengestrol acetate per head per day, 30 to 181.8 g/ton of lasalocid (as Bovatec®) at a rate of 1 mg lasalocid per 2.2 lb body weight daily with a maximum of 360 mg of lasalocid per head per day, and 25 to 2,800 g/ton of chlortetracycline (as Deracin™) at a rate of 350 mg chlortetracycline per head daily The melengestrol acetate Type C top-dress medicated feed must be top dressed onto or mixed at feeding with the Type C medicated feed containing lasalocid and chlortetracycline for not more than 24 days.
Oral
MGA® and Bovatec® and Deracin™
Chickens (13)
Chickens (broilers)
68 (0.0075 percent) to 113 (0.0125 percent) grams lasalocid sodium per ton of feed in combination with roxarsone 45.4 grams per ton of feed plus bacitracin 10 or 30 grams per ton of feed.
Oral
For broiler chickens only. Feed continuously as sole ration. Withdraw 5 days before slaughter.
Avatec® / 3-Nitro® / Albac®
Chickens (broilers)
68 (0.0075 percent) to 113 (0.0125 percent) grams Lasalocid sodium per ton of feed in combination with Roxarsone 45.4 plus bambermycins 1 (0.00011 percent) grams per ton of feed.
Oral
For broiler chickens only. Feed continuously as sole ration. Withdraw 5 days before slaughter.
3-Nitro® / Avatec® / Flavomycin®
Broiler Chickens
68 - 113 g lasalocid sodium per ton of Type C medicated feed. Feed as the sole ration.
Oral
Avatec®
Broiler Chickens
Bambermycins 1 to 2 grams, plus lasalocid 68 to 113 grams.
Oral
Feed continuously as sole ration.
Avatec® / Flavomycin®
Broiler Chickens
Lasalocid: 68 to 113 g/ton Bacitracin zinc: 4 to 50 g/ton
Oral
Feed continuously as the sole ration. For broiler chickens only.
Avatec® / Baciferm®
Chickens (broilers and fryers)
68 (0.0075 percent) to 113 (0.0125 percent) grams Lasalocid sodium per ton of feed in combination with Roxarsone 45.4 grams per ton of feed plus bacitracin (methylene disalicylate) 10 to 25 grams per ton of feed.
Oral
For broiler or fryer chickens only. Feed continuously as the sole ration. Withdraw 5 days before slaughter.
3-Nitro® / Avatec® / Fortracin Broiler Premix
Chickens (broilers and fryers)
68 (0.0075 percent) to 113 (0.0125 percent) grams Lasalocid sodium per ton of feed in combination with Virginiamycin 20 grams per ton of feed.
Oral
For broiler and fryer chickens only. Feed continuously as sole ration. Do not feed to laying chickens.
Avatec® / Stafac®
Chickens (broilers and fryers)
68 (0.0075 percent) grams lasalocid sodium per ton of feed in combination with bacitracin, 10 to 50 grams per ton of feed.
Oral
For broiler or fryer chickens only. Feed continuously as the sole ration.
Avatec® / Fortracin Premix
Chickens (broilers or fryers)
68 (0.0075 percent) grams to 113 (0.0125 percent) grams Lasalocid sodium per ton of feed in combination with Roxarsone, 45.4 (0.005 percent) grams per ton of feed.
Oral
For broiler or fryer chickens only. Feed continuously as the sole ration. As sole source of organic arsenic. Withdraw 5 days before slaughter.
3-Nitro® / Avatec®
Chickens (broiler or fryer)
68 (0.0075 percent) grams Lasalocid sodium per ton of feed in combination with Lincomycin, 2 (0.00022 percent) grams per ton of feed.
Oral
For broiler and fryer chickens only. Feed continuously as sole ration. Withdraw 5 days before slaughter. Type C feed must be used within 4 weeks of manufacture. As lincomycin hydrochloride monohydrate.
Avatec® / Lincomix®
Chicken (broilers)
68 (0.0075 percent) to 113 (0.0125 percent) grams Lasalocid sodium per ton of feed in combination with Roxarsone 45.5 grams per ton of feed plus bacitracin methylene disalicylate 50 grams per ton of feed.
Oral
Feed continuously as the sole ration. As sole source of organic arsenic. Withdraw 5 days before slaughter.
3-Nitro® / Avatec® / BMD®
Broiler and fryer Chickens
Feed continuously as the sole ration 20 g virginiamycin and 68 to 113 g lasalocid sodium per ton of Type C medicated feed for broiler and fryer chickens.
Oral
Do not feed to laying chickens. For broiler or fryer chickens only. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Stafac® and Avatec®
Broiler chickens
68 to 113 g/ton lasalocid sodium and 2 g/ton lincomycin (as lincomycin hydrochloride agricultural grade) in Type C medicated feed. Feed as the sole ration. Do not allow rabbits, hamsters, guinea pigs, horses or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. Do not allow horses or other equines access to Type C feeds containing lasalocid as ingestion may be fatal. Safety of lasalocid for use in unapproved species has not been established.
Oral
Avatec® and LINCOMIX®
Turkeys (6)
Lasalocid: 68 to 113 glton Virginiamycin :10 to 20 g/ton
Oral
Feed continuously as the sole ration For growing turkeys only.
Avatec® / Stafac®
Growing Turkeys
Feed 68 to 113 g/ton lasalocid sodium and 4 to 50 g/ton bacitracin (as feed grade bacitracin zinc) in Type C medicated feed. Feed as the sole ration. Do not allow horses or other equines access to Type C feeds containing lasalocid as ingestion may be fatal. Safety of lasalocid for use in unapproved species has not been established.
Oral
Avatec ® and Albac ®
Growing Turkeys
68 - 113 g lasalocid sodium per ton of Type C medicated feed. Feed as the sole ration.
Oral
Avatec®
Growing Turkeys
Lasalocid sodium: 68 to 113 g/ton Bacitracin methylene disalicylate: 4 to 50 g/ton
Oral
Feed continuously as the sole ration. For growing turkeys only.
Avatec® / BMD®
Growing Turkeys
Lasalocid: 68 to 113 g/ton Bacitracin zinc: 4 to 50 grams per ton of feed.
Oral
Feed continuously as sole ration.
Avatec® / Baciferm®
Turkeys (Growing)
Lasalocid sodium (68 to 113 g/ton) in combination with roxarsone (22.7 to 45.4 g/ton)
Oral
For growing turkeys only. Use as sole source of organic arsenic.
Avatec® plus 3-Nitro®
Rabbits (2)
Rabbits up to 6 ½ weeks of age
113 g lasalocid sodium per ton of Type C medicated feed. Feed as the sole ration to rabbits up to 6 ½ weeks of age.
Oral
Avatec®
113 grams lasalocid per ton of total ration
Oral
Feed as the sole ration for up to 6½ weeks of age.
Bovatec® 68 Type A Medicated Article
Sheep (2)
Sheep Maintained in Confinement
20 - 30 g lasalocid sodium per ton of Type C medicated feed. Feed as the sole ration to provide 15 to 70 mg lasalocid sodium per head per day depending on body weight.
Oral
Bovatec® 150 FP
20-30 grams lasalocid per ton of total ration (90% dry matter)
Oral
Feed continuously to provide not less than 15 mg nor more than 70 mg per head per day depending on body weight.
Bovatec® 68 Type A Medicated Article
Game birds (1)
Chukar Partridges up to 8 weeks of age
113 g lasalocid sodium per ton of Type C medicated feed. Feed as the sole ration to chukar partridges up to 8 weeks of age.
Oral
Avatec®
Please see NADA 140-288 for more information. (1)
Please see NADA 140-288 for more information.
Oral
Please see NADA 140-288 for more information.
Bovatec® / MGA® 100
دون تحديد نوع الحيوان (11)
This product should be further diluted in an intermediate blending step prior to mixing in the final feed. 1. Complete Type C Medicated Feed a. Intermediate blending: Mix 1 part of Bovatec 150 FP (Type A Medicated Article) with 29 parts of finely ground non-medicated feedstuffs to provide an intermediate preblend containing 5 grams of lasalocid sodium per pound. b. Using the 5 g/lb intermediate preblend, the following table would apply to the manufacture of complete Type C medicated feeds: Intended lasalocid sodium concentration in the complete Type C medicated feed Add the following amounts of 5 grams per pound intermediate preblend per ton of complete Type C medicated feed mixed: grams/ton mg/lb lbs/ton 10 5 2 15 7.5 3 30* 15 6 * Maximum approved concentration for complete Type C medicated feeds for growing beef steers and heifers fed in confinement for slaughter and sheep maintained in confinement. c. Using the 5 g/lb intermediate preblend, the following table would apply to the manufacture of other complete Type C medicated feeds and supplements: Daily feeding rate Desired daily lasalocid sodium intake Add the following amounts of 5 grams per pound intermediate preblend per ton of Type C medicated feed or supplement mixed: Lasalocid sodium will be present in the Type C medicated feed or supplement at the following concentration: lbs/head/day mg/head/day lbs/ton grams/ton 1 60 24 120 200 80 400 300 120 600 2 60 12 60 200 40 200 300 60 300 3 60 8 40 200 26.7 133.5 300 40 200 2. Dry Type C Medicated Feed Supplement a. Intermediate blending: Mix 1 part Bovatec 150 FP Type A Medicated Article with 6.5 parts of finely ground non-medicated feedstuffs to provide an intermediate preblend containing 20 grams of lasalocid per pound. For example, mix one 50 lb bag of Bovatec 150 FP Type A Medicated Article with 325 lbs of non-medicated feedstuffs. b. Using the 20 g/lb intermediate preblend, the following table would apply to the manufacture of dry Type C medicated supplements: Intended lasalocid sodium concentration in the Type C medicated feed supplement Add the following amounts of 20 grams per pound intermediate preblend per ton of Type C medicated feed supplement mixed: grams/ton mg/lb lbs/ton 400 200 20 600 300 30 1000 500 50 1440 720 72 1600 800 80 c. Thoroughly mix Type C medicated feed supplement with sufficient non-medicated feedstuffs in accordance with the feeding rates listed in the use directions below. 3. Type C Liquid Medicated Feed Supplement Intended for Addition to Dry Feeds a. Type C liquid medicated feed supplements with suspending agent(s) should be in a pH range of 4-8 and maintain physical stability for up to three months with a viscosity not less than 300 cps. b. Conventional liquid supplements should be in a pH range of 4-8. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air, or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.
ORAL
Bovatec® 150 FP
This product should be further diluted in an intermediate blending step prior to mixing in the final feed. 1. Complete Type C Medicated Feed a.Intermediate blending: Mix 1 part of Bovatec 91 Type A Medicated Article with 17 parts of finely ground non-medicated feedstuffs to provide an intermediate preblend containing 5 grams of lasalocid per pound. b. Using the 5 g/lb intermediate preblend, the following table would apply to the manufacture of complete Type C medicated feed: Intended lasalocid sodium concentration in the complete Type C medicated feed Add the following amounts of 5 grams per pound intermediate preblend per ton of complete Type C medicated feed mixed: grams/ton mg/lb lbs/ton 10 5 2 15 7.5 3 30* 15 6 * Maximum approved concentration for complete Type C medicated feeds for growing beef steers and heifers fed in confinement for slaughter and sheep maintained in confinement. c. Using the 5 g/lb intermediate preblend, the following table would apply to the manufacture of other complete Type C medicated feeds and supplements: Daily feeding rate Desired daily lasalocid sodium intake Add the following amounts of 5 grams per pound intermediate preblend per ton of Type C medicated feed or supplement mixed: Lasalocid sodium will be present in the Type C medicated feed or supplement at the following concentration: lbs/head/day mg/head/day lbs/ton grams/ton 1 60 24 120 200 80 400 300 120 600 2 60 12 60 200 40 200 300 60 300 3 60 8 40 200 26.7 133.5 300 40 200 2. Dry Type C Medicated Feed Supplement a. Intermediate blending: Mix 1 part Bovatec 91 Type A Medicated Article with 3.5 parts of finely ground non-medicated feedstuffs to provide an intermediate preblend containing 20 grams of lasalocid per pound. For example, mix one 50 lb bag of Bovatec 91 Type A Medicated Article with 175 lbs of non-medicated feedstuffs. b. Using the 20 g/lb intermediate preblend, the following table would apply to the manufacture of dry Type C medicated feed supplements: Intended lasalocid sodium concentration in the Type C medicated feed supplement Add the following amounts of 20 grams per pound intermediate preblend per ton of Type C medicated feed supplement mixed: grams/ton mg/lb lbs/ton 400 200 20 600 300 30 1000 500 50 1440 720 72 1600 800 80 c. Thoroughly mix Type C medicated feed supplement with sufficient non-medicated feedstuffs in accordance with the feeding rates listed in the use directions below. 3. Type C Liquid Medicated Feed Supplement Intended for Addition to Dry Feeds a. Type C liquid medicated feed supplements with suspending agent(s) should be in a pH range of 4-8 and maintain physical stability for up to three months with a viscosity not less than 300 cps. b. Conventional liquid supplements should be in a pH range of 4-8. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air, or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.
ORAL
Bovatec® 91
This product should be further diluted in an intermediate blending step prior to mixing in the final feed. Do not feed undiluted. 1. Complete Feed a. Intermediate blending: Mix 1 part of Bovatec 150 FP (Type A Medicated Article) with 29 parts of finely ground nonmedicated feedstuffs to provide an intermediate preblend containing 5 grams of lasalocid per pound. b. Using the 5 g/lb intermediate preblend, the following table would apply to the manufacture of complete feeds: Intended lasalocid concentration in the complete feed Add the following amounts of 5 grams per pound intermediate preblend per ton of complete feed mixed: grams/ton mg/lb lbs/ton 10 5 2 15 7.5 3 30* 15 6 * Maximum approved concentration for complete feeds for cattle fed in confinement for slaughter and sheep in confinement c. Using the 5 g/lb intermediate preblend, the following table would apply to the manufacture of other complete feeds and supplements that do not require further mixing: Daily feeding rate Desired daily lasalocid intake Add the following amounts of 5 grams per pound intermediate preblend per ton of feed or supplement mixed: Lasalocid will be present in the feed or supplement at the following concentration: lbs/head/day mg/head/day lbs/ton grams/ton 1 60 24 120 200 80 400 300 120 600 2 60 12 60 200 40 200 300 60 300 3 60 8 40 200 26.7 133.5 300 40 200 2. Dry Supplement a. Intermediate blending: Mix 1 part Bovatec 150 FP Type A Medicated Article with 6.5 parts of finely ground nonmedicated feedstuffs to provide an intermediate preblend containing 20 grams of lasalocid per pound. For example, mix one 50 lb bag of Bovatec 150 FP Type A Medicated Article with 325 lbs of non-medicated feedstuffs. b. Using the 20 g/lb intermediate preblend, the following table would apply to the manufacture of dry supplements: Intended lasalocid concentration in the supplement Add the following amounts of 20 grams per pound intermediate preblend per ton of supplement mixed: grams/ton mg/lb lbs/ton 400 200 20 600 300 30 1000 500 50 1440 720 72 1600 800 80 c. Thoroughly mix supplement with sufficient non-medicated feedstuffs in accordance with the feeding rates listed in the use directions below. 3. Liquid Supplement Intended for Addition to Dry Feeds a. Supplements with suspending agent(s) should be in a pH range of 4-8 and maintain physical stability for up to three months with a viscosity not less than 300 cps. b. Conventional liquid supplements should be in a pH range of 4-8. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air, or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.
ORAL
Bovatec® 150 FP
Species Dose Indications for use Growing beef steers and heifers fed in confinement for slaughter 10-30 grams lasalocid sodium per ton of total ration (90% dry matter) For improved feed efficiency: Feed as the sole ration to provide 100 to 360 mg lasalocid sodium per head per day. 25-30 grams lasalocid sodium per ton of total ration (90% dry matter) For increased rate of weight gain and improved feed efficiency: Feed as the sole ration to provide 250 to 360 mg lasalocid sodium per head per day. Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef and dairy heifers 60-300 mg lasalocid sodium per head/day For increased rate of weight gain: Feed in at least 1 pound of Type C medicated feed. Intakes of lasalocid sodium greater than 200 mg per head per day have not been shown to be more effective than 200 mg per head per day. 60-300 mg lasalocid sodium per head/day For increased rate of weight gain: Feed on a free-choice basis. Intakes of lasalocid sodium greater than 200 mg per head per day have not been shown to be more effective than 200 mg per head per day. Type C free-choice medicated feed must be manufactured under a medicated feed mill license utilizing an FDA approved formulation. NOTE: Coccidiosis may occur when young pasture cattle are co-mingled with adult cattle passing coccidial oocysts. Cattle up to 800 lbs 1 mg lasalocid sodium per 2.2 lbs body weight/day For control of coccidiosis caused by Eimeria bovis and E. zuernii. Hand feed to provide up to 360 mg lasalocid sodium per head per day. Beef calves less than 2 months of age and dairy calves 1 mg lasalocid sodium per 2.2 lbs body weight/day For control of coccidiosis caused by Eimeria bovis and E. zuernii. Thoroughly mix milk replacer powder with warm water and hand feed immediately. Sheep maintained in confinement 20-30 grams lasalocid sodium per ton of total ration (90% dry matter) For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata: Feed as the sole ration to provide 15 to 70 mg lasalocid sodium per head per day depending on the body weight.
ORAL
Bovatec® 150 FP
Species Dose Indications for use Cattle Fed in Confinement for Slaughter 10-30 grams lasalocid per ton of total ration (90% dry matter) For improved feed efficiency in cattle fed in confinement for slaughter, feed continuously to provide not less than 100 mg nor more than 360 mg per head per day. 25-30 grams lasalocid per ton of total ration (90% dry matter) For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter, feed continuously to provide not less than 250 mg nor more than 360 mg per head per day. Pasture Cattle – slaughter, stocker, feeder cattle, and dairy and beef replacement heifers 60-300 mg lasalocid per head/day For increased rate of weight gain. The drug must be contained in at least 1 pound of feed and fed continuously on a daily basis. 60-300 mg lasalocid per head/day For increased rate of weight gain, feed continuously on a free-choice basis. Free-choice feed must be manufactured under a medicated feed mill license utilizing an FDA approved formulation. Daily lasalocid intakes in excess of 200 mg per head per day have not been shown to be more effective than 200 mg lasalocid per head per day. NOTE: Coccidiosis may occur when young pasture cattle are co-mingled with adult cattle passing coccidial oocysts. Cattle 1 mg lasalocid per 2.2 lbs body weight/day For control of coccidiosis caused by Eimeria bovis and E. zuernii in cattle up to 800 lbs. Hand feed continuously to provide not more than 360 mg per day. Replacement Calves 1 mg lasalocid per 2.2 lbs body weight/day For control of coccidiosis caused by Eimeria bovis and E. zuernii, hand feed in milk replacer powder. Sheep 20-30 grams lasalocid per ton of total ration (90% dry matter) For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata in sheep maintained in confinement. Feed continuously to provide not less than 15 mg nor more than 70 mg per head per day depending on body weight.
ORAL
Bovatec® 150 FP
This product should be incorporated into liquid feed supplements: (1) Agitate Bovatec Liquid 20 before use. (2) Supplements with suspending agent(s) should be in a pH range of 4 - 8 and maintain physical stability for up to three months with a viscosity not less than 300 cps. (3) Conventional liquid supplements should be in a pH range of 4 - 8. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air, or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used. (4) The following is provided as a guide in determining the quantity of Bovatec Liquid 20 (Type A Medicated Article) to be added in preparing liquid feed supplements (LFS). Preparation of intermediate liquid preblend is not recommended. LFS TO BE FED UNDILUTED As a Type C Medicated Feed - Hand-Fed or Top Dressed Amount of LFS to be fed (lbs/head/day) To achieve a lasalocid intake of (mg/head/day) Bovatec Liquid 20 per ton LFS pounds fluid ounces 6.13 gm lasalocid per fluid ounce (Bovatec Liquid 20 specific gravity is 1.035) 0.5 15 0.66 9.8 0.5 60 2.65 39.2 0.5 70 3.09 45.7 0.5 200 8.82 130.5 0.5 300 13.23 195.8 0.5 360 15.88 234.9 1.0 15 0.33 4.9 1.0 60 1.32 19.6 1.0 70 1.54 22.8 1.0 200 4.41 65.3 1.0 300 6.62 97.9 1.0 360 7.94 117.5 LFS TO BE DILUTED As a Type B Medicated Feed - Mixed into a Feed Amount of LFS to be added to final feed (lbs/ton) Lasalocid in final feed (grams/ton) Bovatec Liquid 20 per Ton LFS pounds fluid ounces 100 10 2.21 32.6 100 25 5.51 81.6 100 30 6.62 97.9 150 10 1.47 21.8 150 25 3.68 54.4 150 30 4.41 65.3 200 10 1.10 16.3 200 25 2.76 40.8 200 30 3.31 48.9 DO NOT FEED UNDILUTED
ORAL
Bovatec® Liquid 20
Species Dose Indications for use Cattle Fed in Confinement for Slaughter 10-30 grams lasalocid per ton of total ration (90% dry matter) For improved feed efficiency in cattle being fed in confinement for slaughter, feed continuously to provide not less than 100 mg nor more than 360 mg per head per day. 25-30 grams lasalocid per ton of total ration (90% dry matter) For improved feed efficiency and increased rate of weight gain in cattle being fed in confinement for slaughter, feed continuously to provide not less than 250 mg nor more than 360 mg per head per day. Pasture Cattle – slaughter, stocker, feeder cattle, and dairy and beef replacement heifers 60-300 mg lasalocid per head/day For increased rate of weight gain. The drug must be contained in at least 1 pound of feed and fed continuously on a daily basis. 60-300 mg lasalocid per head/day For increased rate of weight gain, feed continuously on a free-choice basis. A feed mill license is required when the free-choice feed is manufactured using a proprietary formula and/or specifications. Free-choice feed formulations must be FDA-approved. Daily lasalocid intakes in excess of 200 mg per head per day have not been shown to be more effective than 200 mg lasalocid per head per day. NOTE: Coccidiosis may occur when young pasture cattle are co-mingled with adult cattle passing coccidial oocysts. Cattle 1 mg lasalocid per 2.2 lbs body weight/day For control of coccidiosis caused by Eimeria bovis and E. zuernii in cattle up to 800 lbs. Hand feed continuously to provide not more than 360 mg per day. Sheep 20-30 grams lasalocid per ton of total ration (90% dry matter) For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata in sheep maintained in confinement. Feed continuously to provide not less than 15 mg nor more than 70 mg per head per day depending on body weight.
ORAL
Bovatec® Liquid 20
Thoroughly mix the following amounts of Avatec to make one ton of Type C medicated feed to provide from 68 g per ton (0.0075%) to 113 g per ton (0.0125%) lasalocid sodium concentration. When adding less than one pound of Type A medicated article per ton of feed, it is recommended that the Type A medicated article first be mixed with a small amount of unmedicated feed (10-25 lbs.) prior to incorporation into the final Type C medicated feed.. Dosage for use in target species lasalocid sodium % in Type C medicated feed lasalocid sodium g/ton in Type C medicated feed lbs Avatec per ton Type C medicated feed Broiler, Fryer Chickens and Growing Turkeys 0.0075% 0.0100% 0.01125% 68 90.7 102 3/4 1 1 1/8 Broiler, Fryer Chickens, Growing Turkeys, Rabbits, Chukar Partridges 0.0125% 113 1 1/4
ORAL
Avatec®
Broiler, Fryer Chickens and Growing Turkeys Use Avatec® continuously in the feed to provide from 68 g per ton (0.0075%) to 113 g per ton (0.0125%) lasalocid concentration. The dosage range allows adjustment of drug level to severity of exposure. The higher levels are indicated for severe exposure. Consult a poultry disease diagnostician for advice regarding the optimal level of drug. Rabbits Use Avatec® continuously in the feed for rabbits up to 6 1/2 weeks of age to provide 113 g per ton (0.0125%) lasalocid concentration. Chukar Partridges Use Avatec® continuously in the feed for young birds up to 8 weeks of age to provide 113 g per ton (0.0125%) lasalocid concentration.
ORAL
Avatec®
Thoroughly mix the following amounts of Avatec® to make one ton of feed to provide from 68 g per ton (0.0075%) to 113 g per ton (0.0125%) lasalocid concentration. When adding less than one pound of Type A medicated article per ton of feed, it is recommended that the Type A medicated article first be mixed with a small amount of feed (10-25 lbs.) prior to incorporation into the final feed. Dosage for use in target species Concentration % in Feed Lasalocid grams/ton lbs Avatec® per ton feed Broiler, Fryer Chickens and Growing Turkeys 0.0075% 0.0100% 0.01125% 68 90.7 102 3/4 1 1 1/8 Broiler, Fryer Chickens, Growing Turkeys, Rabbits, Chukar Partridges 0.0125% 113 1 1/4
ORAL
Avatec®
Broiler Chickens and Growing Turkeys Feed as the sole ration a Type C medicated feed containing 68 to 113 g per ton (0.0075 to 0.0125%) lasalocid sodium. The dosage range allows adjustment of drug level to severity of exposure. The higher levels are indicated for severe exposure. Consult a poultry disease diagnostician for advice regarding the optimal level of drug. Rabbits up to 6 1/2 weeks of age Feed as the sole ration a Type C medicated feed containing 113 g per ton (0.0125%) lasalocid sodium. Chukar Partridges up to 8 weeks of age Feed as the sole ration a Type C medicated feed containing 113 g per ton (0.0125%) lasalocid sodium
ORAL
Avatec®
التراكيز المتوفرة (62)
| المنتج | الشكل الصيدلاني | التراكيز المتوفرة |
|---|---|---|
| HeifermaX® 500 plus Bovatec® | Medicated Feed | Liquid Type A article containing 500 milligrams per pound. |
| HeifermaX® 500 plus Bovatec® and Tylan™ | Medicated Feed | Dry Type A medicated articles containing 100 or 200 milligrams per pound or liquid Type A article containing 500 milligrams per pound |
| Aureomycin® and Bovatec® | Type A Medicated Article | Type A medicated article containing 50, 70, 80, 90, or 100 grams of chlortetracycline hydrochloride (as chlortetracycline calcium complex) per pound. Type A medicated article containing 91 or 150 grams of lasalocid (as lasalocid sodium) per pound. Type A liquid medicated article containing 90.7 grams of lasalocid (as lasalocid sodium) per pound. |
| Aureomycin® and Bovatec® | Type A Medicated Article | Type A medicated article containing 50, 70, 80, 90, or 100 grams of chlortetracycline hydrochloride (as chlortetracycline calcium complex) per pound. Type A medicated article containing 91 or 150 grams of lasalocid (as lasalocid sodium) per pound. Type A liquid medicated article containing 90.7 grams of lasalocid (as lasalocid sodium) per pound. |
| Aureomycin® and Bovatec® | Type A Medicated Article | Type A medicated article containing 50, 70, 80, 90, or 100 grams of chlortetracycline hydrochloride (as chlortetracycline calcium complex) per pound. Type A medicated article containing 91 or 150 grams of lasalocid (as lasalocid sodium) per pound. Type A liquid medicated article containing 90.7 grams of lasalocid (as lasalocid sodium) per pound. |
| Aureomycin® and Bovatec® | Type A Medicated Article | Type A medicated article containing 50, 70, 80, 90, or 100 grams of chlortetracycline hydrochloride (as chlortetracycline calcium complex) per pound. Type A medicated article containing 91 or 150 grams of lasalocid (as lasalocid sodium) per pound. Type A liquid medicated article containing 90.7 grams of lasalocid (as lasalocid sodium) per pound. |
| Avatec® / Stafac® | Medicated Feed | Lasalocid: Type A medicated article in a concentration of 90.7 grams lasalocid activity per pound. Virginiamycin: Type A medicated article in concentrations of 20 and 227 grams of virginiamycin activity per pound. |
| Purina Sugar Mag Block 1440 BVT Medicated Mineral Block | Medicated Feed Block | 1440 g/ton in the Type C Free-choice Mineral Block. |
| Avatec ® and Albac ® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | Type A medicated article containing 90.7 grams of lasalocid sodium per pound. Type A medicated article containing feed grade bacitracin zinc equivalent to 50 grams bacitracin per pound. |
| Avatec® / BMD® | Medicated Feed | Lasalocid sodium: Type A medicated article in a concentration of 90.7 grams lasalocid sodium activity per pound. Bacitracin methylene disalicylate: Type A medicated article in concentrations of 10, 25, 30, 40, 50, 60, or 75 grams bacitracin activity per pound. |
| Crystalyx® Iono-Lyx® | Type C free-choice medicated feed | A Type C free-choice medicated feed |
| Avatec® | Medicated Feed | Each pound of Type A medicated article contains 90.7 grams (20%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| Avatec® | Medicated Feed | Each pound of Type A medicated article contains 90.7 grams (20%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| Avatec® | Medicated Feed | Each pound of Type A medicated article contains 90.7 grams (20%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| Avatec® | Medicated Feed | Each pound of Type A medicated article contains 90.7 grams (20%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| Bovatec® 150 FP | Medicated Feed | Each pound of Type A medicated article contains 150 grams (33.1%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| Bovatec® 150 FP | Medicated Feed | Each pound of Type A medicated article contains 150 grams (33.1%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| Bovatec® 150 FP | Medicated Feed | Each pound of Type A medicated article contains 150 grams (33.1%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| Bovatec® 150 FP | Medicated Feed | Each pound of Type A medicated article contains 150 grams (33.1%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| Bovatec® 150 FP | Medicated Feed | Each pound of Type A medicated article contains 150 grams (33.1%) lasalocid sodium. A minimum of 90% of lasalocid sodium is lasalocid A. |
| MGA®/ Bovatec®/ Tylovet® 100 | Medicated Feed | Melengestrol acetate – 200 and 500 g/lb Lasalocid sodium – 68 and 91 g/lb Tylosin phosphate - 40 and 100 g/lb |
| Avatec® / Baciferm® | Medicated Feed | Lasalocid is supplied as a Type A medicated article containing 90.7 grams lasalocid activity per pound. Bacitracin zinc is supplied as a Type A medicated article in a concentrations of 50 grams bacitracin activity per pound. |
| Avatec® / Fortracin Premix | Medicated Feed | Type A medicated articles approved 3.0, 3.3, 3.8, 4.0, 4.3, 4.4, 5.0, 5.1, 5.5, 5.7, 6.0, 6.3, 6.7, 7.2, 7.5, 8.0, 8.3, 10.0, 12.5, 15, 20, and 50 percent activity. |
| 3-Nitro® / Avatec® / Lincomycin | Medicated Feed | Type A medicated articles approved: 3.0, 3.3, 3.8, 4.0, 4.3, 4.4, 5.0, 5.1, 5.5, 5.7, 6.0, 6.3, 6.7, 7.2, 7.5, 8.0 8.3, 10.0, 12.5, 15, 20, and 50 percent activity. |
| 3-Nitro® / Avatec® / Flavomycin® | Medicated Feed | Type A medicated articles: 3.0, 3.3, 3.8, 4.0 4.3, 4.4, 5.0, 5.1, 5.5, 5.7, 6.0, 6.3, 6.7, 7.2, 7.5, 8.0 8.3, 10.0, 12.5, 15, 20, and 50 percent activity. |
| 3-Nitro® / Avatec® | Medicated Feed | Type A medicated articles approved for 3.0, 3.3, 3.8, 4.0 4.3, 4.4, 5.0, 5.1, 5.5, 5.7, 6.0, 6.3, 6.7, 7.2, 7.5, 8.0 8.3, 10.0, 12.5, 15, 20, and 50 percent activity. |
| Avatec® / Stafac® | Medicated Feed | Type A medicated articles approved for 15 percent activity. |
| Avatec® / Flavomycin® | Medicated Feed | Lasalocid is supplied as a Type A medicated article in a concentration of 90.7 grams lasalocid activity per pound. Bambermycins is supplied as a Type A medicated article in concentrations of 2, 4 or 10 grams bambermycins activity per pound. |
| Avatec® / Baciferm® | Medicated Feed | Lasalocid is supplied as a Type A medicated article containing 90.7 grams lasalocid activity per pound. Bacitracin zinc is supplied as a Type A medicated article in a concentration of 50 grams bacitracin activity per pound. |
| Avatec® / Lincomix® | Medicated Feed | Type A medicated articles with 15 percent activity. |
| Avatec® plus 3-Nitro® | Type A Medicated Article | Type A medicated articles containing lasalocid sodium (90.7 g/lb (20 %)) and roxarsone (90.7 g/lb (20%)). |
| 3-Nitro® / Avatec® / Baciferm® | Medicated Feed | Type A medicated articles approved for 3.0, 3.3, 3.8, 4.0, 4.3, 4.4, 5.0, 5.1, 5.5, 5.7, 6.0, 6.3, 6.7, 7.2, 7.5, 8.0, 8.3, 10.0, 12.5, 15, 20, and 50 percent activity. |
| 3-Nitro® / Avatec® / Fortracin Broiler Premix | Medicated Feed | Type A medicated articles approved for 3.0, 3.3, 3.8, 4.0, 4.3, 4.4, 5.0, 5.1, 5.5, 5.7, 6.0, 6.3, 6.7, 7.2, 7.5, 8.0, 8.3, 10.0, 12.5, 15, 20, and 50 percent activity. |
| Bovatec® and TM® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | Type A medicated articles containing 68, 90.7, or 150 grams lasalocid sodium per pound. Type A medicated articles containing 50 or 100 grams of oxytetracycline (from oxytetracycline quaternary salt) equivalent to oxytetracycline hydrochloride per pound. |
| Bovatec® / MGA® 100 | Medicated Feed | Please see NADA 140-288 for more information. |
| MGA® and Bovatec® | Medicated Feed | Type A medicated article (MGA® 200) containing 200 milligrams of melengestrol acetate per pound or Type A liquid medicated article (MGA® 500) containing 500 milligrams of melengestrol acetate per pound. Type A medicated article containing 90.7 or 150 grams of lasalocid sodium per pound (Bovatec® 91 or Bovatec® 150 FP) or Type A liquid medicated article (Bovatec® Liquid 20) containing 90.7 grams of lasalocid sodium per pound. |
| MGA® and Bovatec® and Tylan™ | Type A Medicated Article | Type A medicated article containing 100 or 200 milligrams of melengestrol acetate per pound or Type A liquid medicated article containing 500 milligrams of melengestrol acetate per pound. Type A medicated article containing 68, 91, or 150 grams of lasalocid (as lasalocid sodium) per pound or Type A liquid medicated article containing 90.7 grams of lasalocid (as lasalocid sodium) per pound. Type A medicated article containing 40 or 100 grams of tylosin (as tylosin phosphate) per pound. |
| MoorMan's® Cattle Minerals BT | Type C free-choice medicated feed | 1,440 g/ton lasalocid (as lasalocid sodium) |
| Stafac® and Avatec® | Type A Medicated Article | Virginiamycin: 10, 20, 50, or 227 g/lb. virginiamycin. Lasalocid sodium: 90.7 g/lb. lasalocid sodium |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Deracin® plus Bovatec® | Type A Medicated Article | Chlortetracycline 50 g/lb, 90 g/lb, and 100 g/lb; Lasalocid 90.7 g/lb, and 150 g/lb |
| Avatec® and LINCOMIX® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | Type A medicated article containing 90.7 grams lasalocid sodium per pound. Type A medicated article containing 20 or 50 grams lincomycin (as lincomycin hydrochloride agricultural grade) per pound. |
| Aureo S 700® and Bovatec® | Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds | Aureo S 700®: 35 g/lb of chlortetracycline calcium complex equivalent to chlortetracycline HCl and 7.7% (35 g/lb) sulfamethazine (1:1 ratio); Bovatec®: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity) |
| Aureo S 700® and Bovatec® | Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds | Aureo S 700®: 35 g/lb of chlortetracycline calcium complex equivalent to chlortetracycline HCl and 7.7% (35 g/lb) sulfamethazine (1:1 ratio); Bovatec®: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity) |
| MGA® and Bovatec® and Aureomycin® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: Melengestrol acetate at 200 mg per pound; MGA® 500: Melengestrol acetate at 500 mg per pound (as melengestrol acetate and its propylene glycol ketal); Bovatec® 91: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid (as lasalocid sodium activity); Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Aureomycin® 50 Granular A: Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Meal: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Granular: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 100 Granular: Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb. |
| MGA® and Bovatec® and Aureomycin® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: Melengestrol acetate at 200 mg per pound; MGA® 500: Melengestrol acetate at 500 mg per pound (as melengestrol acetate and its propylene glycol ketal); Bovatec® 91: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid (as lasalocid sodium activity); Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Aureomycin® 50 Granular A: Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Meal: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Granular: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 100 Granular: Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb. |
| MGA® and Bovatec® and Aureomycin® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: Melengestrol acetate at 200 mg per pound; MGA® 500: Melengestrol acetate at 500 mg per pound (as melengestrol acetate and its propylene glycol ketal); Bovatec® 91: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid (as lasalocid sodium activity); Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Aureomycin® 50 Granular A: Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Meal: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Granular: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 100 Granular: Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb. |
| MGA® and Bovatec® and Aureomycin® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: Melengestrol acetate at 200 mg per pound; MGA® 500: Melengestrol acetate at 500 mg per pound (as melengestrol acetate and its propylene glycol ketal); Bovatec® 91: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid (as lasalocid sodium activity); Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Aureomycin® 50 Granular A: Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Meal: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Granular: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 100 Granular: Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb. |
| MGA® and Bovatec® and Aureomycin® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: Melengestrol acetate at 200 mg per pound; MGA® 500: Melengestrol acetate at 500 mg per pound (as melengestrol acetate and its propylene glycol ketal); Bovatec® 91: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid (as lasalocid sodium activity); Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Aureomycin® 50 Granular A: Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Meal: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Granular: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 100 Granular: Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb. |
| MGA® and Bovatec® and Aureomycin® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: Melengestrol acetate at 200 mg per pound; MGA® 500: Melengestrol acetate at 500 mg per pound (as melengestrol acetate and its propylene glycol ketal); Bovatec® 91: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid (as lasalocid sodium activity); Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Aureomycin® 50 Granular A: Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Meal: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Granular: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 100 Granular: Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb. |
| MGA® and Bovatec® and Aureomycin® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: Melengestrol acetate at 200 mg per pound; MGA® 500: Melengestrol acetate at 500 mg per pound (as melengestrol acetate and its propylene glycol ketal); Bovatec® 91: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid (as lasalocid sodium activity); Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Aureomycin® 50 Granular A: Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Meal: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Granular: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 100 Granular: Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb. |
| MGA® and Bovatec® and Aureomycin® | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: Melengestrol acetate at 200 mg per pound; MGA® 500: Melengestrol acetate at 500 mg per pound (as melengestrol acetate and its propylene glycol ketal); Bovatec® 91: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid (as lasalocid sodium activity); Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid (as lasalocid sodium activity); Aureomycin® 50 Granular A: Chlortetracycline calcium complex equivalent to 50 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Meal: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 90 Granular: Chlortetracycline calcium complex equivalent to 90 g chlortetracycline hydrochloride per lb.; Aureomycin® 100 Granular: Chlortetracycline calcium complex equivalent to 100 g chlortetracycline hydrochloride per lb. |
| MGA® and Bovatec® and Deracin™ | Type A medicated articles to be used in the manufacture of Type C medicated feeds | MGA® 200: 200 mg/lb of melengestrol acetate; MGA® 500: 500 mg/lb of melengestrol acetate; Bovatec® 91: 90.7 g/lb (20%) of lasalocid; Bovatec® 150 FP: 150 g/lb (33.1%) of lasalocid; Bovatec® Liquid 20: 90.7 g/lb (20%) of lasalocid; Deracin™ 50 Meal: 50 g/lb of chlortetracycline; Deracin™ 90 Meal: 90 g/lb of chlortetracycline; Deracin™ 100 Meal: 100 g/lb of chlortetracycline |
| — | — | 150 g / 0.45 kg |
| — | — | 90.7 g / 0.45 kg |